Business Context and Reporting Period
Cytosorbents Corp filed a Form 8-K Current Report on July 6, 2017, regarding events occurring on June 30, 2017. The filing focuses on a financing event rather than a standard periodic financial report.
Key Financial Metrics
- Debt Facility: The Company drew down an additional $5 million term loan under its existing Loan and Security Agreement with Western Alliance Bank.
- Total Principal: The total principal amount of the loan facility is now $10 million.
- Repayment Terms: The interest-only payment period for both term loans was extended by six months through December 31, 2017.
- Amortization: Following the interest-only period, the loan will undergo 30 months of straight-line amortization.
- Maturity Date: The facility matures on July 1, 2020.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or overall liquidity beyond the specific loan details.
Material Changes
The primary material change is the increase in total debt principal from $5 million to $10 million and the extension of the interest-only period, which alters the company's near-term cash flow obligations regarding principal repayment.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operations, or specific risk factors beyond the terms of the debt agreement. The event is reported as an "Other Event" (Item 8.01) with the full press release filed as an exhibit.
Investor Verification Checklist
- Verify the total outstanding debt balance of $10 million in the company's most recent 10-Q or 10-K.
- Confirm the interest rate applicable to the new $5 million drawdown.
- Review the amended Loan and Security Agreement for any new covenants or collateral requirements triggered by the additional drawdown.
- Assess the impact of the extended interest-only period on the company's cash burn rate through December 2017.